You are here

  • Home
  • Online First
  • Bypass surgery is more cost-effective than percutaneous coronary interventions for most patients with multivessel or left main coronary artery disease

Article Text

Article menu

other Versions

Download PDFPDF
Economic analysis
Randomised controlled trial
Bypass surgery is more cost-effective than percutaneous coronary interventions for most patients with multivessel or left main coronary artery disease
  1. Shikhar Agarwal,
  2. Samir R Kapadia
  1. Cleveland Clinic—Heart and Vascular Institute, Cleveland, Ohio, USA
  1. Correspondence to: Dr Samir R Kapadia, Cleveland Clinic—Heart and Vascular Institute, Cleveland, OH 44195, USA; kapadis{at}ccf.org

https://doi.org/10.1136/ebmed-2014-110121

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Cohen DJ, Osnabrugge RL, Magnuson EA, et al; SYNTAX Trial Investigators. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 2014;130:1146–57.

    Context

    The SYNTAX (SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery) trial compared outcomes of percutaneous coronary intervention (PCI) with drug eluting stents (DES) and coronary artery bypass grafting (CABG) among patients with three-vessel or left main coronary artery disease (CAD).1 At 5-year follow-up, there was a lower incidence of a composite of cardiovascular death, myocardial infarction (MI), stroke or repeat vascularisation among patients undergoing CABG, compared with PCI. This was primarily driven by reductions in MI and repeat vascularisation.2 The …

    View Full Text

    Footnotes

    • Competing interests None.

    • Provenance and peer review Commissioned; internally peer reviewed.